Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies

被引:0
作者
Kenji Miki
Makoto Ohta
Manabu Abe
Hiroki Yoshimatsu
Koichi Fujii
Nozomi Ebata
Christine R. West
Mark T. Brown
Glenn Pixton
Naoki Isogawa
机构
[1] Osaka Yukioka College of Health Science,
[2] Hayaishi Hospital,undefined
[3] Pfizer R&D Japan,undefined
[4] Pfizer Japan Inc.,undefined
[5] Pfizer Inc.,undefined
来源
Pain and Therapy | 2022年 / 11卷
关键词
Osteoarthritis; WOMAC pain and physical function; PGA-OA; Tanezumab; Joint safety; Rapidly progressive osteoarthritis; Pain measurement; Treatment outcome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:827 / 844
页数:17
相关论文
共 77 条
[1]  
Muraki S(2009)Prevalence of radiographic knee osteoarthritis and its association with knee pain in the elderly of Japanese population-based cohorts: the ROAD study Osteoarthr Cartil 17 1137-1143
[2]  
Oka H(2016)Prevalence of radiographic hip osteoarthritis and its association with hip pain in Japanese men and women: the ROAD study Osteoarthr Cartil 24 117-123
[3]  
Akune T(2019)Patterns of drug treatment in patients with osteoarthritis and chronic low back pain in Japan: a retrospective database study J Pain Res 12 1631-1648
[4]  
Iidaka T(2017)Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data BMJ 357 j1909-779
[5]  
Muraki S(2013)Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials Lancet 382 769-118
[6]  
Akune T(2012)Cardiovascular risk with nonsteroidal anti-inflammatory drugs (NSAIDs): the urological perspective BJU Int 110 E437-847
[7]  
Akazawa M(2016)Nonsteroidal anti-inflammatory drugs and risk of incident heart failure: a systematic review and meta-analysis of observational studies Clin Cardiol 39 111-1412
[8]  
Mimura W(2013)Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications J Pharm Pharm Sci 16 821-17
[9]  
Togo K(2011)Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study Osteoarthr Cartil 19 1405-48
[10]  
Bally M(2015)A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee Osteoarthr Cartil 23 S8-810